Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management | BMJ Evidence-Based Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Evidence synthesis

General medicine

Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

Online download statistics by month:

Online download statistics by month: February 2020 to August 2023

	Abstract	Full	Pdf
Feb 2020	260	255	45
Mar 2020	610	592	386
Apr 2020	345	332	131
May 2020	315	307	58
Jun 2020	177	167	43
Jul 2020	100	92	27
Aug 2020	82	78	23
Sep 2020	69	66	20
Oct 2020	48	45	27
Nov 2020	173	168	43
Dec 2020	151	135	39
Jan 2021	98	90	36
Feb 2021	56	48	12
Mar 2021	83	77	20
Apr 2021	74	72	13
May 2021	81	80	23
Jun 2021	80	73	22
Jul 2021	89	77	17
Aug 2021	53	51	15
Sep 2021	62	57	13
Oct 2021	67	63	24
Nov 2021	50	47	38
Dec 2021	50	45	97
Jan 2022	48	47	17
Feb 2022	81	76	24
Mar 2022	44	40	21
Apr 2022	72	73	17
May 2022	56	52	21
Jun 2022	51	48	14
Jul 2022	38	38	5
Aug 2022	41	40	9
Sep 2022	57	57	16
Oct 2022	41	38	9
Nov 2022	28	22	12
Dec 2022	28	27	12
Jan 2023	39	31	19
Feb 2023	37	34	7
Mar 2023	17	15	10
Apr 2023	19	15	19
May 2023	24	18	27
Jun 2023	17	15	4
Jul 2023	29	26	33
Aug 2023	28	25	11
Total	3968	3754	1479